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In Brief
Zhou et al. show that early generation of
reactive oxygen species (ROS) is required
for nuclear reprogramming of somatic
cells to pluripotency. Genetic knockdown
and knockout of the oxidative enzyme
Nox (1–4), or addition of antioxidants,
suppresses reprogramming. The findings
provide insight into mechanisms by
which pluripotent stem cells may be
generated.
Cell Reports
ReportOptimal ROS Signaling Is Critical
for Nuclear Reprogramming
Gang Zhou,1 Shu Meng,1 Yanhui Li,1 Yohannes T. Ghebre,1 and John P. Cooke1,*
1Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute (HMRI),
6670 Bertner Avenue, Houston, TX 77030, USA
*Correspondence: jpcooke@houstonmethodist.org
http://dx.doi.org/10.1016/j.celrep.2016.03.084SUMMARY
Efficient nuclear reprogramming of somatic cells to
pluripotency requires activation of innate immunity.
Because innate immune activation triggers reactive
oxygen species (ROS) signaling, we sought to deter-
mine whether there was a role of ROS signaling in nu-
clear reprogramming. We examined ROS production
during the reprogramming of doxycycline (dox)-
inducible mouse embryonic fibroblasts (MEFs) car-
rying the Yamanaka factors (Oct4, Sox2, Klf4, and
c-Myc [OSKM]) into induced pluripotent stem cells
(iPSCs). ROS generation was substantially increased
with the onset of reprogramming. Depletion of
ROS via antioxidants or Nox inhibitors substan-
tially decreased reprogramming efficiency. Similarly,
both knockdown and knockout of p22phox—a critical
subunit of the Nox (1–4) complex—decreased re-
programming efficiency. However, excessive ROS
generation using genetic and pharmacological ap-
proaches also impaired reprogramming. Overall,
our data indicate that ROS signaling is activated
early with nuclear reprogramming, and optimal levels
of ROS signaling are essential to induce pluripo-
tency.INTRODUCTION
The generation of induced pluripotent cells (iPSCs) is associated
with a metabolic switch from oxidative phosphorylation (in the
somatic cells) to glycolysis (in the pluripotent cells) (Folmes
et al., 2011; Xu et al., 2013). In comparison to somatic cells,
iPSCs have smaller and fewer mitochondria, synthesize less
ATP, and preferentially generate energy by glycolysis (Folmes
et al., 2011; Prigione et al., 2010). Furthermore, iPSCs propagate
better in low oxygen conditions (Haneline, 2008), generate less
reactive oxygen species (ROS) and are sensitive to ROS-
induced apoptosis (Wu et al., 2013). Mitochondrial activity is
restrained in iPSCs (Armstrong et al., 2010; Folmes et al.,
2011; Prigione et al., 2010), so iPSCs utilize the pentose phos-
phate shunt to generate energy andmaterials for synthesis of nu-
cleotides (Zhang et al., 2012).This is an open access article under the CC BY-NParadoxically, in the current paper, we show evidence that the
effective generation of iPSCs begins with an early increase in
reactive oxygen species (ROS) in the reprogramming of somatic
cells. This oxidative activity is tamed in later stages of nuclear re-
programming by an upregulation of antioxidant enzymes. These
surprising findings are nevertheless consistent with our previous
observation that activation of innate immunity is required for effi-
cient nuclear reprogramming (Lee et al., 2012). Innate immune
signaling during reprogramming inducesNF-kB- and IRF3-medi-
ated changes in the expression of epigenetic modifiers that favor
an open probability state of the chromatin (Lee et al., 2012).
It is generally accepted that activation of innate immunity in so-
matic cells is associated with a substantial increase in ROS
signaling (Nathan and Cunningham-Bussel, 2013; Panday
et al., 2015; Yang et al., 2013b). However, whether ROS signaling
plays a role in the process of nuclear reprogramming from so-
matic cells (e.g., fibroblasts) to iPSCs was heretofore uncharted
territory. In this study, we delineate the role of ROS signaling in
reprogramming. Our observations reveal that both the intensity
and kinetics of ROS signaling are critical for efficient nuclear
reprogramming.RESULTS
iPSCs Maintain Low ROS Status
We generated iPSCs by using secondary doxycycline (dox)-
inducible mouse embryonic fibroblasts (MEFs) at passage 3.
The mature iPSC colonies were characterized by positive stain-
ing for Oct4, Sox2, and stage-specific embryonic antigen 1
(SSEA1) (Figure S1A). These colonies expressed high levels of
Sox2, Nanog, and Oct4 (Figure S1B). Intracellular levels of
ROS (by flow cytometry using dihydroethidium [DHE] or CM-
H2DCFDA) were 50% lower in iPSCs by comparison to parental
MEFs (Figure 1A).We confirmed these results using a redox-sen-
sitive GFP (roGFP) (Waypa et al., 2010) (Figure 1B). These data
indicate that iPSCs maintain low levels of intracellular ROS.
Next, we examined the expression of key ROS regulators. The
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
(Nox) family members were downregulated in iPSCs, with the
exception of DUOX1/2 and p67phox (Figure 1C). Interestingly,
p67phox is known to inhibit Nox2 activity (Krishnaiah et al.,
2013). We then examined antioxidant genes and found that
SOD1/2 and Gpx (Figure 1D) were upregulated. These findings
are consistent with a low level of intracellular ROS in iPSCs.Cell Reports 15, 919–925, May 3, 2016 ª2016 The Authors 919
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. iPSCs Have Low ROS Levels in
Comparison to MEFs
(A) Left: flow cytometry of DHE and CM-H2DCFDA
staining for ROS in iPSCs and MEFs. Right:
quantitation of flow cytometry data. Data are
represented as mean ± SD, n = 3. See also Fig-
ure S1.
(B) Ratiometric measurements of redox status by
roGFP2. Data are represented as mean ± SE,
n = 4. *p < 0.05; **p < 0.01; ***p < 0.001.
(C) mRNA levels of ‘‘oxidant’’ genes in iPSCs
relative to MEFs. Data are represented as mean ±
SD, n = 3.
(D) mRNA levels of ‘‘anti-oxidant’’ genes as indi-
cated in iPSCs relative to MEFs. Data are repre-
sented as mean ± SD, n = 3.Nuclear Reprogramming Is Associated with Increased
ROS Levels and NFkB-Mediated Nox2 Upregulation
We examined intracellular ROS levels during reprogramming
and observed an early increase in ROS that gradually decreased
over time (Figure 2C). We found that Nox1 was upregulated
10-fold at day 2, returning to basal values by day 6 (Figure 2A).
Notably, Nox2, an enzyme reported to be differentially ex-
pressed in phagocytic cells for immune defense (Nauseef,
2008), was upregulated by 70-fold during the early stage of re-
programming (Figure 2A). The increased expression of Nox2
was inhibited 70% by BAY117085 (20 mM), an irreversible in-
hibitor of IkBa phosphorylation (Figure 2D). This observation is
consistent with previous observations that NF-kB signaling in-
duces Nox2 expression (Anrather et al., 2006). In addition, the
inhibition of NF-kB decreased reprogramming efficiency by
50% (Figure 2E). Other components of Nox2 complex,
p22phox and p67phox, were also upregulated during reprogram-
ming (Figure 2B). Since ROS level is determined by both gener-
ation and elimination, we also examined the expression of genes
encoding antioxidant proteins. Major antioxidant genes were
upregulated later during reprogramming (Figures S2A and
S2B), in association with the expression of Nrf2, a sensor of
ROS (Figure S2C).
ROS Signaling Is Required in Early Phase of Nuclear
Reprogramming
We next assessed the effect of manipulating ROS levels during
reprogramming. Pharmacological manipulation was performed
either at early (days 1–7) or at later (days 8–14) phases of
reprogramming (Figures 3A, 3B, S3C, and S3D) using selective
ROS scavengers (EUK134, Ebselen, and Mito-TEMPO) and
Nox inhibitors (DPI and Apocynin). Each of these well-character-
ized antioxidants were observed to reduce ROS levels in
fibroblasts (Figure S4). Early depletion of ROS substantially
decreased AP-positive colony yield (Figures 3A and 3B). How-920 Cell Reports 15, 919–925, May 3, 2016ever, no effect was observed with late
administration of antioxidants (Figures
S3C and S3D). We further defined the
dynamics of ROS signaling by adminis-
tering antioxidants at different points dur-
ing reprogramming (Figure S3B). ROSsignaling was most critical in the first 2 days of reprogramming
(Figures S3E–S3G).
To further confirm the role of ROS signaling in nuclear reprog-
ramming, we performed knockdown (KD) and knockout (KO)
studies of p22phox as it is the essential subunit for Nox complexes
1–4. A 90% KD of expression was achieved and maintained at
days 3 and 6 of reprogramming (Figure 3C). We observed that
p22phox KD reduced AP-positive colony yields (Figure 3D).
Next, we generated p22phox KO 3T3 cell line using CRISPR/
Cas9 technology. Using PAGE (Figure S3H) and genomic DNA
(gDNA) sequencing (Figure S3I), we validated that there was a
453bpdeletion between intron 2 and exon 4of p22phox gene (Fig-
ure 3J). Consistent with p22phox KD studies, p22phox KO 3T3 cells
have impaired ability to reprogram (Figure 3E).
Excessive ROS Impairs Nuclear Reprogramming
Efficiency
To determine if increased ROS levels could increase or accel-
erate nuclear reprogramming, we examined the effect of genetic
or pharmacological measures to increase ROS levels. Overex-
pression of Nox2 (Figures S4 and S5) increased ROS levels as
shown by DHE. Intriguingly, the overexpression of Nox2 actually
decreased reprogramming efficiency (Figure 4A). GSH synthesis
inhibitor, buthionine sulfoximine (BSO), decreased the genera-
tion of AP-positive colonies by 50% at 50 mM (Figure 4B). By
the addition of exogenous hydrogen peroxide, we observed a
biphasic pattern with a tendency for an increase in iPSC yield
at a low dose of H2O2, with impaired reprogramming efficiency
at higher doses (Figure 4C).
DISCUSSION
Innate Immunity and Generation of iPSCs
We previously found that activation of innate immunity is
required for efficient nuclear reprogramming of somatic cells to
Figure 2. NF-kB Upregulates Nox2 during
Nuclear Reprogramming
(A) mRNA levels of Nox isoforms during nuclear
reprogramming process. Data are represented as
mean ± SD, n = 3.
(B) mRNA levels of Nox complex components
during nuclear reprogramming. Data are repre-
sented as mean ± SD, n = 3.
(C) Time course of ROS status during nuclear re-
programming. DHE staining for ROS was per-
formed every other day as indicated. Detailed
methods are described in the Experimental Pro-
cedures. Data are represented asmean±SD, n= 3.
(D) NF-kB inhibitor inhibits Nox2 expression. Re-
programming was initiated by adding ES media
containing 2 mg/ml of Dox in the absence or
presence of BAY117085 (20 mM). Nox2 message
was examined at day 1 after reprogramming. Data
are represented as mean ± SD, n = 3.
(E) NF-kB inhibitor impairs reprogramming effi-
ciency. Reprogramming was performed in the
absence or presence of BAY117085 (20 mM) for
the first 4 days. AP-positive colonies were counted
at day 21. Data are represented as mean ± SD,
n = 6. *p < 0.05.
See also Figure S2.pluripotency (Lee et al., 2012). The retroviral vectors carrying the
Yamanaka factors activate pattern recognition receptors (PRRs)
such as Toll-like receptor 3 (TLR3), which triggers innate immune
signaling. This signaling pathway causes global changes in
epigenetic modifiers, such as downregulation of histone deace-
tylase (HDAC) family members and upregulation of histone ace-
tyltransferases (HATs). Mediated by NF-kB and IRF-3, these
changes result in greater epigenetic plasticity, facilitating the ac-
tion of the Yamanaka transcription factors (Lee et al., 2012).
Innate Immunity Activates ROS Signaling
Reactive oxygen species (ROS) signaling is triggered by activa-
tion of innate immunity (Yang et al., 2013a). Furthermore, NF-kB
is activated by ROS intermediates (Bonizzi et al., 1999; Escobar
et al., 2012). Interestingly, NF-kB also induces the expression of
Nox2 (gp91phox) in MEFs (Anrather et al., 2006). Thus, activation
of innate immunity may induce a positive feedback cycle of ROS
signaling. Because ROS signaling alsomodulates differentiation,
senescence, apoptosis, and proliferation (Dro¨ge, 2002), ROS
generation and elimination is tightly regulated. Whereas oxida-
tive phosphorylation is predominant in somatic cells, iPSCs exist
in a glycolytic state through upregulation of glycolytic enzymes
and downregulation of electron transport chain (ETC) subunits
(Folmes et al., 2011). Furthermore, antioxidant genes (e.g.,
UCP2 [Zhang et al., 2011], SOD2, and Gpx2) are upregulated
in iPSC and downregulated during differentiation (Saretzki
et al., 2008). As a result, stem cells generate low levels of ROS
during proliferation andmaintenance (Haneline, 2008). However,
it is not known if ROS signaling plays a role in the nuclear reprog-
ramming to pluripotency.
To address this question, we focused on the NADPH oxidases
(Nox1–4) and Dual oxidase (Duox1/2) family of proteins because
these are the major sources of non-mitochondrial ROS in
mammalian cells (Lambeth et al., 2007). Among the Nox familymembers, Nox2 is a key member of the family that complexes
with various subunits including p22phox, p40phox, p47phox,
p67phox, and Rac to form a functional oxidase. The cellular levels
of ROS are counter-regulated by scavengers and antioxidants,
whose expression is determined by transcription factors such
as nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Nrf2 is a
member of the ‘‘cap-and-collar’’ (Cnc) transcription factors
that are involved in the regulation of many antioxidants (Kobaya-
shi and Yamamoto, 2005) and in metabolic control of prolifer-
ating cells (DeNicola et al., 2011; Hayes and Ashford, 2012;
Hochmuth et al., 2011). Recently, it has been reported that
Nrf2 controls self-renewal and pluripotency in human embryonic
stem cells (Jang et al., 2014).
ROS Levels in iPSCs
By comparison to parental murine embryonic fibroblasts, we
show that murine iPSCs have low ROS levels consistent with
the known metabolic switch in iPSCs (Zhu et al., 2010). This
reduction in ROS levels is associated with downregulation of
members of the Nox family and upregulation of genes encoding
antioxidant proteins. We find Gpx2 is highly induced particularly
in the later stages of nuclear reprogramming and its expression is
then maintained at a high level in iPSCs. The increased expres-
sion of antioxidant enzymes maintains intracellular levels of
ROS at a low level in iPSCs (Chen et al., 2008). By maintaining
a low level of ROS generation, iPSCs limit the risk of cellular
and genomic damage during self-renewal and prevent differen-
tiation (Naka et al., 2008; Saretzki et al., 2008).
Early ROS Signaling Is Required for Nuclear
Reprogramming
Notably, we find that an early increase in ROS signaling is
required during the initial stage of nuclear reprogramming. We
observe marked upregulation of Nox2 during reprogramming,Cell Reports 15, 919–925, May 3, 2016 921
Figure 3. Early ROS Repression Impairs Nu-
clear Reprogramming Efficiency
(A and B) Selective scavengers (25 mM EUK134,
50 mM Ebselen, and 100 mM Mito-TEMPO) (A) and
Nox inhibitors (50 nM DPI and 10 mM Apocynin) (B)
decrease AP-positive iPSC colonies. Data are rep-
resented as mean ± SD, n = 6. **p < 0.01; ***p <
0.001; ****p < 0.0001. See also Figure S3.
(C) Knockdown of p22phox. The mRNA level was
examined by qRT-PCR at days 3 and 6 of re-
programming. Data are represented as mean ± SD,
n = 3.
(D and E) p22phox (D) knockdown and (E) knockout
decrease AP-positive iPSC colonies. Data are rep-
resented as mean ± SD, n = 6. See also Figures
S3H–S3J.associated with an increase in ROS levels. Pharmacological and
genetic attenuation of the Nox (1–4) complex in the early phase
of reprogramming impairs reprogramming efficiency. Inhibition
of Nox family members reduces oxidative stress and increases
genomic stability (Pazhanisamy et al., 2011). By contrast, acti-
vation of ROS signaling in lung epithelial cells is known to
reduce HDAC and to increase HATs activity (Rahman et al.,
2004). Furthermore, activation of tightly regulated Nox com-
plexes produces hydrogen peroxide (H2O2) from superoxide
(O2
). Hydrogen peroxide, a signaling molecule (Winterbourn,
2008), modifies specific cysteine residues in target proteins to
influence the fate of cells (Hall et al., 2009). Indeed, cysteine
oxidation of transcriptional factors or epigenetic modifiers
may affect pluripotency (Boland et al., 2014; Ramakrishna
et al., 2014).
The ROS-induced reprogramming to pluripotency seems to
be largely due to cytosolic sources (e.g., Nox2) as EUK and
ebselen are most effective at reducing the generation of iPSCs.
However, there is also a modest reduction of iPSC yield in the
presence of the mitochondrially directed antioxidant, mito-
TEMPO. These data indicate that ROS derived from mitochon-
drial respiration are also involved in nuclear reprogramming. Of
note, there appears to be a critical period during which these
antioxidants are effective. Specifically, when added from the
start of reprogramming, the antioxidants can substantially block
iPSC generation (with EUK inhibiting iPSC yield by over 90%).
When added after 2 days, the antioxidants have little or no effect.
These data are consistent with the observations using the antag-
onists of Nox activity. Both DPI or Apocyanin can substantially
reduce iPSC yield when added during the first 7 days, but have922 Cell Reports 15, 919–925, May 3, 2016no effect when added during the last
7 days, of the reprogramming process.
Excessive ROS Signaling Impairs
Reprogramming
Wewere surprised that genetic or pharma-
cological measures to increase ROS gen-
eration actually impaired reprogramming
to pluripotency. A cell line overexpressing
Nox 2 generated fewer iPSCs. Further-
more, the addition of BSO (for the first12 days of reprogramming) to inhibit the synthesis of glutathione,
a major endogenous antioxidant, was also associated with
impaired iPSC generation. Finally, treating the reprogramming
cells with exogenous H2O2 (for the first 12 days of reprogram-
ming) revealed a biphasic response, with a tendency for low
doses of H2O2 to facilitate, whereas higher doses of H2O2
impaired, the generation of iPSCs. Although these observations
were initially unexpected, they are consistent with the fact that
senescent somatic cells, which typically exhibit higher ROS
levels, are more difficult to reprogram (Banito et al., 2009). Our
studies indicate that an optimal level of ROS signaling is required
for effective reprogramming.
Furthermore, these data are also consistent with the upregula-
tion of antioxidant enzymes late in the reprogramming process,
orchestrated in part by Nrf2 (Niture et al., 2014). Normally, Nrf2
is sequestered in the cytosol by Keap1, and released by ROS
signaling (DeNicola et al., 2011). Keap1 has multiple reactive
cysteine residues, which makes it a target of ROS and electro-
philes (Dinkova-Kostova et al., 2002). In addition to activation
by ROS, Nrf2 also can be activated by Keap1-independent
phosphorylation (Li et al., 2012; Rojo et al., 2012). We find that
the expression of Nrf2 is increased gradually and then plateaus
during late reprogramming. Upregulation of antioxidant enzymes
accompanies this activation of Nrf2. The temporal course of ROS
generation that we observe during reprogramming is in part ex-
plained by the early upregulation of Nox2, followed later by an
upregulation of antioxidant enzymes. Thus, there appears to
be a careful orchestration of ROS levels during reprogramming,
with an early phase characterized by increased ROS levels that is
required for effective generation of iPSCs. In later stages, ROS
Figure 4. Accumulation of ROS Impairs Nuclear Reprogramming
(A) Overexpression of Nox2 decreased AP-positive colony yield. To over-
express Nox2 in secondary Dox-inducible MEFs, cells were plated in a 6-well
plate at 3 3 105 cells/well. After 12 hr serum starvation, Nox2 (Cybb, from
Origene) plasmids were introduced via FuGENE 6 according tomanufacturer’s
instruction. Two days after Nox2 overexpression, reprogramming was initiated
and AP-positive colony numbers were counted at day 21. Data are repre-
sented as mean ± SD, n = 6. ***p < 0.001. See also Figure S4.
(B) Buthionine sulfoximine (BSO) decreased AP-positive colony yield. Nuclear
reprogramming was initiated in the presence of 50 mM BSO until day 12. Data
are represented as mean ± SD, n = 6. *p < 0.05.
(C) H2O2 decreased AP-positive colony yield in a dose-dependent manner.
Nuclear reprogramming was initiated in the presence of H2O2 until day 12.
Data are represented as mean ± SD, n = 6. **p < 0.01.
See also Figure S5.signaling does not seem to be required, and in fact may be
deleterious.
ROS Biology in Adult Stem Cells
Recently, the importance of ROS signaling in the regulation of
stem cell fate has been appreciated (Le Belle et al., 2011; Mori-
moto et al., 2013; Paul et al., 2014; Wang et al., 2013). ROS
signaling plays an important role in adult stem cell proliferationand differentiation (Hamanaka et al., 2013; Hom et al., 2011;
Jang et al., 2014; Malinska et al., 2012; Owusu-Ansah and Bane-
rjee, 2009; Paul et al., 2014; Tormos et al., 2011; van Galen et al.,
2014; Wang et al., 2013). The importance of ROS levels in prolif-
eration of adult stem cells is tissue-specific (Naka et al., 2008;
Wang et al., 2013). Adult stem cells maintaining high levels of
ROS have been found to be more proliferative (Paul et al.,
2014). By contrast, ROS levels are maintained at lower levels in
hematopoietic stem cells and mammary epithelial stem cells
than their mature progeny, so as to facilitate self-renewal (Juntilla
et al., 2010; Naka et al., 2008; Toyokuni, 2006; Zhang et al.,
2008). Paul et al. (2014) showed that low-to-moderate ROS level
is required for self-renewal and proliferation of mouse and hu-
man airway basal stem cells.
In conclusion, our study shows that ROS signaling is
required in the early stages of nuclear reprogramming to plurip-
otency. In the later phase of reprogramming, upregulation
of antioxidant mechanisms is observed, and mature iPSC
colonies exist in a cellular environment with low levels of intracel-
lular ROS.
EXPERIMENTAL PROCEDURES
Reagents and Cells
The reagents and cells used in this study, and their sources, are more fully
described in the Supplemental Experimental Procedures. For isolation of sec-
ondary dox-inducible MEFs, chimeric embryos were obtained from transgenic
R26rtTA; Col1a12lox-4F2A mice expressing the loxP-flanked, dox-inducible
polycistronic 4F2A cassette (Oct4, Sox2, Klf4, c-Myc). Secondary MEFs
were isolated as previously described (Wernig et al., 2008) and expanded for
two passages before freezing. Passage 3 cells were used in all the experiments
unless indicated otherwise. Culture plates were coated with 0.1% gelatin so-
lution for 30 min before use. All cells were cultured in ES medium under stan-
dard condition (5% CO2, 37
C) unless stated otherwise. Alkaline phosphatase
staining for enumeration of colonies is described in the supplementary section.
For generation of RNAi and transduction, see the Supplemental Experimental
Procedures. For generation of iPSCs with piggyBac transposon system, we
used plasmids PB-CAG-rtTA and PB-TET-MKOS (c-Myc, Klf4, Oct4, and
Sox2 ORFs linked with 2A peptide sequences) provided by Dr. Andras
Nagy. The pCyL43 PB transposase plasmid was from Wellcome Trust Sanger
Institute.
Molecular and Biochemical Assays
Predesigned TaqMan probes were purchased from Life Technologies. RNA
isolated from cells was reverse-transcribed by qScript cDNA SuperMix.
qPCR was performed using QuantStudio 12k Flex Real-Time PCR System.
Normalized 2DDCt was calculated and compared with control. To assess
ROS levels dihydroethidium (DHE) was dissolved in DMSO and diluted
into cell imaging medium to 5 mM final concentration. Incubation was per-
formed at 37C for 30 min in dark. Data were quantified by measuring fluo-
rescence intensity at 518 nm excitation and 606 nm emission. In some
studies, cells were transfected by adenovirus expressing cyto-roGFP2 or
mito-roGFP2 (Waypa et al., 2010) to assess intracellular ROS levels by fluo-
rescence intensity. All experiments were repeated at least three times. Stu-
dent’s t test or a nonparametric Mann-Whitney U test was employed to
compare differences between two groups. p value < 0.05 was considered
statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
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